Eastern Bank’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,863
Closed -$1.43M 201
2022
Q4
$1.43M Hold
28,863
0.08% 113
2022
Q3
$938K Hold
28,863
0.05% 121
2022
Q2
$1.14M Hold
28,863
0.06% 116
2022
Q1
$2.02M Hold
28,863
0.09% 106
2021
Q4
$2.25M Hold
28,863
0.1% 109
2021
Q3
$2.75M Buy
28,863
+16,090
+126% +$1.7M 0.13% 99
2021
Q2
$1.59M Hold
12,773
0.08% 113
2021
Q1
$1.68M Hold
12,773
0.09% 109
2020
Q4
$1.69M Buy
+12,773
New +$1.54M 0.09% 105

Other funds holding EXAS

Eastern Bank's EXAS Position: Q1 2023 in Review

Eastern Bank sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 28,863 shares — an estimated $1.43M sold.

Eastern Bank first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $2.75M in Q3 2021. 582 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Eastern Bank reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Eastern Bank sold 28,863 Exact Sciences shares in Q1 2023, an estimated $1.43M.
  • Eastern Bank first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • Eastern Bank's Exact Sciences position peaked at $2.75M in Q3 2021.
  • 582 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Eastern Bank's 13F filing for Q1 2023, filed 19 Apr 2023.